Navidea Biopharmaceuticals, Inc. (NAVBQ) Financials

NAVBQ Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 5.7 million 8.7 million
June 30, 2023 8.2 million 9.0 million
March 31, 2023 2.4 million 11.9 million
Dec. 31, 2022 4.4 million 12.5 million

NAVBQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -10.3 million 10
June 30, 2023 4.6 million -33842
March 31, 2023 -1.8 million 72
Dec. 31, 2022 -2.5 million 41

NAVBQ Net Income

No data available :(

NAVBQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 3.9 million - 10696
June 30, 2023 6.1 million - 19564
March 31, 2023 33795 2.0 million 11298
Dec. 31, 2022 2.0 million 1.9 million 20288

NAVBQ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 99.4 million
June 30, 2023 48.2 million
March 31, 2023 32.7 million
Dec. 31, 2022 32.4 million

NAVBQ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 16523 829613 1.3 million -
June 30, 2023 65337 1.1 million 1.3 million -
March 31, 2023 39409 1.3 million 1.2 million -
Dec. 31, 2022 72039 1.9 million 1.3 million -

NAVBQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 36030
June 30, 2023 - 36378
March 31, 2023 - 36550
Dec. 31, 2022 610 50036

NAVBQ Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NAVBQ

Price: $0

52 week price:
0.00
0.04

Payout Ratio Range:
-3.63%
0.13%

Earnings Per Share: -0.20 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 10008

Links: